Health News

SAN FRANCISCO--(BUSINESS WIRE)--Deepinvent, a Silicon Valley superintelligence company advancing solutions for humanity’s challenges, today revealed the winners of the Deepinvent4Good Inventathon, the world’s first virtual competition empowering innovators to transform bold ideas into meaningful, positive inventions. Out of hundreds of submissions from innovators around the world, the top three winners met all competition requirements and judges' praise for innovation. “Deepinvent4Good has been...

CARROLLTON, Ga.--(BUSINESS WIRE)--Mercer University School of Medicine (MUSM) has announced a new partnership with Tanner Health to establish a regional campus for clinical training in Carrollton, where third- and fourth-year medical students will live, learn and train during the final two years of their education. The Carrollton clinical campus will allow students to gain experience in a tertiary care setting that serves largely rural communities — further advancing the school’s mission to imp...

VENLO, Netherlands--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE. QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) ("QIAGEN" or the "Company") announces the final terms of the new senior, unsecur...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. Announces New Lease Agreement for Six California Facilities...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today that its management team will be attending the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at the Sheraton New York Times Square Hotel in New York, NY. About Octave Bioscience, Inc. Octave Bioscience, Inc. is a commercial stage preci...

SEATTLE--(BUSINESS WIRE)--Lakefield Veterinary Group, a leader in providing exceptional veterinary care across the United States, has been recognized as one of the fastest-growing companies in America by Inc. Magazine. The company has secured a place on the prestigious Inc. 5000 list, which highlights the most dynamic and successful businesses in the country based on revenue growth. This recognition underscores Lakefield Veterinary Group's commitment to excellence in veterinary care, its dedica...

BETHESDA, Md.--(BUSINESS WIRE)--Aledade today announced the appointment of two national health care leaders, Shawn Guertin and Joneigh S. Khaldun, M.D., to its Board of Directors....

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that Interim Chief Executive Officer Ian F. Smith will present at the following upcoming investor conferences: Cantor Global He...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will participate in a fireside chat hosted by J.P. Morgan on Friday, September 5th, at 1:00 p.m. (ET). The live webcast of the fireside chat can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in s...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma (STS) in combination with chemotherapy. This approval marks the ninth indication fo...